Literature DB >> 3156578

Lipopolysaccharide tolerance inhibits eye inflammation. I. Reduced immune complex or lipopolysaccharide effects.

E L Howes, M E Goldyne, H D Perez, I M Goldstein, J T Rosenbaum.   

Abstract

The effect of endotoxin tolerance on ocular inflammation was studied in rabbits. A single intravenous (IV) injection of endotoxin (bacterial lipopolysaccharide [LPS]) produced a mild acute iridocyclitis. Repeated daily (five to seven days) IV injections of LPS (5 micrograms extracted from Salmonella typhimurium) led to a state of refractoriness or LPS "tolerance," and ocular inflammation was no longer produced. In contrast to controls, in rabbits tolerant to LPS, IV LPS failed to elevate prostaglandin E2, thromboxane B2, or chemotactic factors in the aqueous humor. Rabbits tolerant to LPS also resisted the increase in vascular permeability normally induced by an ocular reversed passive Arthus reaction. These results demonstrated that LPS tolerance can induce anti-inflammatory effects in the eye.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156578     DOI: 10.1001/archopht.1985.01050020109031

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

Review 1.  Anterior uveitis: clinical and research perspectives.

Authors:  J T Rosenbaum; T M Martin; S R Planck
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Why HLA-B27? My thirty-year quest: the Friedenwald lecture.

Authors:  James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

3.  Endotoxin tolerance diminishes certain antiinflammatory effects of endotoxin.

Authors:  J T Rosenbaum; K T Hartiala; E L Howes; I M Goldstein
Journal:  Inflammation       Date:  1985-09       Impact factor: 4.092

4.  The reduction of inflammatory responses in lipopolysaccharide-tolerant eyes.

Authors:  P Bhattacherjee; A Parke
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

5.  Uveitis induction in the rabbit by muramyl dipeptides.

Authors:  R V Waters; T G Terrell; G H Jones
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.